Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636779 · ClinicalTrials.gov registry record
BraveNet Integrative Medicine Descriptive Study
A clinical trial of Healthy, sponsored by Duke University.
- Completed
- Registry status
- 4,340
- Enrollment target
- 8
- Study locations
NCT00636779 is a study of Healthy that has completed, run by Duke University. The registered enrollment target is 4,340 participants, above the 643-participant average among 1,090 other Healthy trials with a reported enrollment target (575% higher). The trial reports 8 study locations across 6 states.
The verdict
NCT00636779, a study of Healthy, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 4,340 participants
- Enrollment target
- 8
- Study locations
Study Summary
The Bravewell Integrative Medicine Research Network (BraveNet) is a newly formed practice-based research network of nine leading integrative medicine centers around the U.S. collaborating in clinical outcomes research to increase the knowledge and evidence-base of integrative medicine.
Conditions Studied
Study Locations (8)
California
- Scripps Center for Integrative Medicine - La Jolla
- Osher Center for Integrative Medicine - San Francisco
- Venice Family Clinic - Santa Monica
Maryland
- University of Maryland Center for Integrative Medicine - Baltimore
Minnesota
- Penny George Institute for Health and Healing - Minneapolis
North Carolina
- Duke Integrative Medicine - Durham
Ohio
- Alliance Center for Integrative Medicine - Cincinnati
Pennsylvania
- Jefferson-Myrna Brind Center of Integrative Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,340 participants |
| Start Date | 2008-03 |
| Est. Completion | 2011-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00636779
The ClinicalTrials.gov registry entry for NCT00636779 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,340 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 643-participant average among 1,090 other Healthy trials with a reported enrollment target (575% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.
NCT00636779 reports 8 study locations spanning 6 distinct geographic areas - top geographies include California, Maryland, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00636779 about?
NCT00636779 is a clinical study titled "BraveNet Integrative Medicine Descriptive Study". The Bravewell Integrative Medicine Research Network (BraveNet) is a newly formed practice-based research network of nine leading integrative medicine centers around the U.S. collaborating in clinical outcomes research to increase the knowledge and evidence-base of integrative medicine.
What is the current status of trial NCT00636779?
This trial is currently completed. The enrollment target is 4,340 participants. The study started on 2008-03. Estimated completion is 2011-06.
What conditions does trial NCT00636779 study?
This clinical trial studies the following conditions: Healthy.
Who is sponsoring clinical trial NCT00636779?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00636779 being conducted?
This trial has 8 study locations across California, Maryland, Minnesota, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.